Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older.

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS ...

Bavarian Nordic's own pipeline is led by its universal COVID-19 booster candidate, which is due to start phase 3 later this year, and respiratory syncytial virus (RSV) candidate that should ...

Valneva will work with local health authorities and wholesalers on the French island territory to distribute the vaccines.

About Bavarian NordicBavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox ...

The chikungunya virus virus-like particle vaccine is well tolerated and shows high immunogenicity in both previous recipients ...

Good day and thank you for standing by. Welcome to the Bavarian Nordic 2024 Annual Report Conference call. At this time all participants are in a listen-only mode. After the speakers' presentation ...

COPENHAGEN, Denmark, March 7, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has validated the marketing ...

COPENHAGEN, Denmark, February 28, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the European Commission has granted marketing authorization in Europe for VIMKUNYA ® for active ...

According to manufacturer Bavarian Nordic, health care providers and travel clinics will now be able to stock the vaccine for individuals visiting areas where there is an increased risk for ...